Technology
Health
Medical

InspireMD

$0.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0007 (0.44%) Today
+$0.0001 (0.06%) After Hours

Why Robinhood?

You can buy or sell InspireMD and other stocks, options, ETFs, and crypto commission-free!

About

InspireMD, Inc., also called InspireMD, is a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. Read More The company was founded in 2005 and is headquartered in Tel Aviv, Israel.

Employees
43
Headquarters
Tel Aviv, Tel Aviv
Founded
2005
Market Cap
6.11M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.89M
High Today
$0.16
Low Today
$0.1531
Open Price
$0.1552
Volume
194.96K
52 Week High
$3.19
52 Week Low
$0.1304

Collections

Technology
Health
Medical
2013 IPO
Asia (Non-China)
Asia

News

Seeking AlphaFeb 19

InspireMD -3% on Q4 results

InspireMD (NSPR) Q4 results: Revenues: $0.82M (-1.2%). Net Loss: ($2.2M) (+60.0%); Loss Per Share: ($0.05) (+99.3%); Quick Assets: $9.4M (+154.1%). The Company is on-track to submit U.S. IDE in mid-2019. Shares are down 3% premarket. Previously: InspireMD reports Q4 results (Feb. 19)...

6,486

Earnings

-$7.38
-$4.92
-$2.46
$0.00
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 6, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.